Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men

被引:177
作者
Park, SH [1 ]
Kim, BI [1 ]
Yun, JW [1 ]
Kim, JW [1 ]
Park, DI [1 ]
Cho, YK [1 ]
Sung, IK [1 ]
Park, CY [1 ]
Sohn, CI [1 ]
Jeon, WK [1 ]
Kim, H [1 ]
Rhee, EJ [1 ]
Lee, WY [1 ]
Kim, SW [1 ]
机构
[1] Sungkyunkwan Univ Sch Med, Div Gastroenterol, Dept Internal Med, Kangbuk Samsung Hosp, Seoul 110746, South Korea
关键词
C-reactive protein; homeostasis model assessment; inflammation; insulin resistance; non-alcoholic fatty liver disease;
D O I
10.1111/j.1440-1746.2004.03362.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: Although insulin resistance is often considered the link between obesity and non-alcoholic fatty liver disease (NAFLD), the role of insulin resistance, independent of obesity, as a NAFLD risk factor in non-obese men has been less well established. Systemic inflammation may be accompanied by insulin resistance in healthy subjects. The goal of the present study was to examine if insulin resistance and systemic inflammatory markers are independent predictors of NAFLD in non-obese men. Methods: The authors conducted a cross-sectional survey of 120 patients with NAFLD and 240 controls matched by age and body mass index. Controls had no evidence of alcohol abuse, hepatitis B or C, obesity, or previous history of diabetes, fasting hyperglycemia or hypertension. Diagnosis of NAFLD was based on an elevated alanine aminotransferase level and sonographic evidence of a fatty liver. Insulin resistance was determined using a homeostasis model assessment (HOMA-IR). Results: The age-adjusted risk of developing NAFLD was strongly associated with the elevated levels in measurements of uric acid, fasting blood sugar, triglycerides, apolipoprotein B, C-reactive protein (CRP) and HOMA-IR, and decreased levels of high density lipoprotein cholesterol and apolipoprotein A-I. Multivariate analysis based on univariate analysis indicated that an increase in CRP (odds ratio [OR] = 1.37; 95% confidence interval [CI]: 1.06-1.77) per 1 SD (1.48 mg/L) and HOMA-IR (OR = 2.28; 95% CI: 1.67-3.11) per 1 SD (0.63) were independent risk factors for NAFLD. Conclusion: Insulin resistance and systemic inflammatory response are of key importance for inducing NAFLD, particularly in apparently healthy non-obese men. (C) 2004 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:694 / 698
页数:5
相关论文
共 24 条
[1]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]   DIFFERENCES IN LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN [J].
CAMPOS, H ;
MCNAMARA, JR ;
WILSON, PWF ;
ORDOVAS, JM ;
SCHAEFER, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :30-35
[3]   IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner [J].
Chikano, S ;
Sawada, K ;
Shimoyama, T ;
Kashiwamura, SI ;
Sugihara, A ;
Sekikawa, K ;
Terada, N ;
Nakanishi, K ;
Okamura, H .
GUT, 2000, 47 (06) :779-786
[4]   Steatohepatitis: A tale of two "hits"? [J].
Day, CP ;
James, OFW .
GASTROENTEROLOGY, 1998, 114 (04) :842-845
[5]   Cytokine expression in hepatocytes: Role of oxidant stress [J].
Dong, WM ;
Simeonova, PP ;
Gallucci, R ;
Matheson, J ;
Fannin, R ;
Montuschi, P ;
Flood, L ;
Luster, MI .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (08) :629-638
[6]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47
[7]   Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam study [J].
Hak, AE ;
Pols, HAP ;
Stehouwer, CDA ;
Meijer, J ;
Kiliaan, AJ ;
Hofman, A ;
Breteler, MMB ;
Witteman, JCM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) :4398-4405
[8]   INVOLVEMENT OF THE HEMOSTATIC SYSTEM IN THE INSULIN-RESISTANCE SYNDROME - A STUDY OF 1500 PATIENTS WITH ANGINA-PECTORIS [J].
JUHANVAGUE, I ;
THOMPSON, SG ;
JESPERSEN, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12) :1865-1873
[9]  
KNIGHT TM, 1992, BRIT HEART J, V67, P343
[10]   Insulin resistance syndrome and fibrinolytic activity: The Northern Sweden MONICA Study [J].
Lindahl, B ;
Asplund, K ;
Eliasson, M ;
Evrin, PE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (02) :291-299